Published in Clin Infect Dis on December 28, 2005
Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis (2010) 4.56
Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis (2010) 2.86
Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther (2007) 2.65
Immune reconstitution inflammatory syndrome: incidence and implications for mortality. AIDS (2012) 1.88
HIV & immune reconstitution inflammatory syndrome (IRIS). Indian J Med Res (2011) 1.84
Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med (2008) 1.76
Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS One (2010) 1.62
Biomarkers of HIV Immune Reconstitution Inflammatory Syndrome. Biomark Med (2008) 1.55
Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none. Nat Rev Microbiol (2012) 1.45
Inpatient health services utilization among HIV-infected adult patients in care 2002-2007. J Acquir Immune Defic Syndr (2010) 1.39
The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial. Ann Intern Med (2012) 1.32
Anterior segment manifestations of human immunodeficiency virus/acquired immune deficiency syndrome. Indian J Ophthalmol (2008) 1.32
Diagnosis & treatment of tuberculosis in HIV co-infected patients. Indian J Med Res (2011) 1.30
Immune restoration diseases reflect diverse immunopathological mechanisms. Clin Microbiol Rev (2009) 1.21
Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy. Expert Rev Anti Infect Ther (2011) 1.20
Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique. PLoS One (2011) 1.13
Pediatric HIV immune reconstitution inflammatory syndrome. Curr Opin HIV AIDS (2008) 1.13
Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164. J Infect Dis (2012) 1.12
Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children. J Acquir Immune Defic Syndr (2009) 1.11
Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa. PLoS One (2012) 1.10
Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy. PLoS One (2013) 1.08
Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs. Immunol Rev (2013) 1.08
HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy. Blood (2011) 1.02
Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy. Curr Opin HIV AIDS (2008) 1.00
The immune reconstitution inflammatory syndrome related to HIV co-infections: a review. Eur J Clin Microbiol Infect Dis (2011) 0.99
Immune reconstitution inflammatory syndrome in human immunodeficiency virus-infected children in Peru. Pediatr Infect Dis J (2009) 0.97
HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome. Semin Immunopathol (2015) 0.97
The clinical pattern, prevalence, and factors associated with immune reconstitution inflammatory syndrome in Ugandan children. AIDS (2010) 0.96
Increased risk of genital ulcer disease in women during the first month after initiating antiretroviral therapy. J Acquir Immune Defic Syndr (2009) 0.95
Polychromatic immunophenotypic characterization of T cell profiles among HIV-infected patients experiencing immune reconstitution inflammatory syndrome (IRIS). AIDS Res Ther (2009) 0.92
Long-term safety from the raltegravir clinical development program. Curr HIV Res (2011) 0.91
Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma. Infect Agent Cancer (2008) 0.90
Blocking type I interferon production: a new therapeutic option to reduce the HIV-1-induced immune activation. Clin Dev Immunol (2011) 0.88
CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 2: discussion of neuro-immune reconstitution inflammatory syndrome with and without other pathogens. AJNR Am J Neuroradiol (2012) 0.87
Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term combination antiretroviral therapy. PLoS One (2014) 0.86
Aggressive extranodal peripheral T-cell non-Hodgkin's lymphoma: A rare case report and review. J Oral Maxillofac Pathol (2014) 0.86
The immune reconstitution inflammatory syndrome. Indian J Dermatol (2011) 0.85
Effects of highly active antiretroviral therapy and its adherence on herpes zoster incidence: a longitudinal cohort study. AIDS Res Ther (2013) 0.84
Antiretroviral therapy in Indian setting: when & what to start with, when & what to switch to? Indian J Med Res (2011) 0.84
Chronic immune activation in HIV-1 infection contributes to reduced interferon alpha production via enhanced CD40:CD40 ligand interaction. PLoS One (2012) 0.84
Neuroradiological features of the tuberculosis-associated immune reconstitution inflammatory syndrome. Int J Tuberc Lung Dis (2010) 0.84
Progressive hypertrophic genital herpes in an HIV-infected woman despite immune recovery on antiretroviral therapy. Infect Dis Obstet Gynecol (2008) 0.82
Hospitalization risk following initiation of highly active antiretroviral therapy. HIV Med (2009) 0.82
Immune restoration disease and changes in CD4+ T-cell count in HIV- infected patients during highly active antiretroviral therapy at Zewditu memorial hospital, Addis Ababa, Ethiopia. AIDS Res Ther (2010) 0.81
Immune reconstitution inflammatory syndrome and the influence of T regulatory cells: a cohort study in The Gambia. PLoS One (2012) 0.79
Molluscum contagiosum as a skin manifestation of immune reconstitution inflammatory syndrome in an AIDS patient who is receiving HAART. Korean J Fam Med (2012) 0.78
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066). Infection (2013) 0.78
Immunological Signaling During Herpes Simplex Virus-2 and Cytomegalovirus Vaginal Shedding After Initiation of Antiretroviral Treatment. Open Forum Infect Dis (2016) 0.78
Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo). Antimicrob Agents Chemother (2012) 0.78
Predictive factors of herpes zoster HIV-infected patients: another adverse effect of crack cocaine. PLoS One (2013) 0.77
Thirty years of the human immunodeficiency virus epidemic and beyond. Int J Oral Sci (2013) 0.77
Transient expansion of activated CD8(+) T cells characterizes tuberculosis-associated immune reconstitution inflammatory syndrome in patients with HIV: a case control study. J Inflamm (Lond) (2013) 0.77
Unmasking Immune Reconstitution Inflammatory Syndrome (IRIS): A report of five cases and review of the literature. Sultan Qaboos Univ Med J (2011) 0.77
A Case report: Herpes zooster IRIS in pregnancy. Afr Health Sci (2009) 0.76
Immune reconstitution inflammatory syndrome-associated Burkitt lymphoma after combination antiretroviral therapy in HIV-infected patients. Clin Lymphoma Myeloma Leuk (2014) 0.75
Acute Cryptococcal Immune Reconstitution Inflammatory Syndrome in a Patient on Natalizumab. Open Forum Infect Dis (2016) 0.75
Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines. AIDS Res Ther (2017) 0.75
Extensive Giant Molluscum Contagiosum in a HIV Positive Patient. J Clin Diagn Res (2015) 0.75
Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease. PLoS One (2016) 0.75
Immune reconstitution syndrome in a human immunodeficiency virus infected child due to giardiasis leading to shock. J Family Med Prim Care (2016) 0.75
Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines. AIDS Res Ther (2017) 0.75
Development of cryptococcal immune reconstitution inflammatory syndrome 41 months after the initiation of antiretroviral therapy in an AIDS patient. AIDS Res Ther (2015) 0.75
Clinician and patient recognition of anogenital herpes disease in HIV positive men who have sex with men. Sex Transm Dis (2011) 0.75
[Immune reconstitution inflammatory syndrome (IRIS)]. Z Rheumatol (2008) 0.75
Immune reconstitution inflammatory syndrome associated with pulmonary pathogens. Eur Respir Rev (2017) 0.75
Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A (1997) 8.05
Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc Natl Acad Sci U S A (2000) 3.66
Race and socio-economic status in survival from breast cancer. J Chronic Dis (1982) 3.08
Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Health Technol Assess (2013) 2.06
Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J Med Genet (2005) 2.04
The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics (1996) 1.81
Requirement for B cell linker protein (BLNK) in B cell development. Science (1999) 1.74
Relationship between CD4 count and CD4% in HIV-infected people. Int J Epidemiol (1997) 1.67
Thrombocytopenia in hypothermia: a common but poorly recognised complication. Br Med J (Clin Res Ed) (1985) 1.61
Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease. J Virol (1999) 1.61
Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut (2003) 1.48
The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic. J Infect (2001) 1.43
Superbugs: are we at the threshold of a new Dark Age? Hosp Med (1998) 1.39
Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown. J Neurosci Res (1997) 1.29
Neuronal activity in narcolepsy: identification of cataplexy-related cells in the medial medulla. Science (1991) 1.25
Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1. Am J Med Genet (1996) 1.24
Ethnic differences in stage of presentation of adults newly diagnosed with HIV-1 infection in south London. HIV Med (2005) 1.16
Dopamine receptor genes are associated with age at first sexual intercourse. J Biosoc Sci (1999) 1.14
Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infection. Eur J Immunol (2001) 1.14
Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor. Am J Pathol (1995) 1.13
Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors. Clin Exp Immunol (2002) 1.13
Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews. Health Technol Assess (2013) 1.11
A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics (1996) 1.10
Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry (1997) 1.04
Non-progression in HIV infection. AIDS (1994) 1.03
Does an HIV clinical trial information booklet improve patient knowledge and understanding of HIV clinical trials? HIV Med (2001) 1.01
Prostate-specific targeting using PSA promoter-based lentiviral vectors. Cancer Gene Ther (2001) 1.00
Neutralization of primary and T-cell line adapted isolates of human immunodeficiency virus type 1: role of V3-specific antibodies. J Gen Virol (1998) 1.00
Delayed diagnosis of cervical cancer in young women. J Obstet Gynaecol (2005) 0.98
Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load. Eur J Immunol (2001) 0.97
How generalizable are the results of large randomized controlled trials of antiretroviral therapy? HIV Med (2000) 0.96
Isoforms of platelet-derived growth factor and its receptors in epiretinal membranes: immunolocalization to retinal pigmented epithelial cells. Exp Eye Res (1995) 0.95
Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London. HIV Med (2005) 0.94
Fetal globin expression in New World monkeys. J Biol Chem (1996) 0.94
Surveillance for outbreaks of influenza-like illness in the institutionalized elderly. Epidemiol Infect (2009) 0.94
Multiple pulmonary leiomyomatous hamartomas in women. J Thorac Cardiovasc Surg (1976) 0.94
1H MR spectroscopy of the brain in HIV-1-seropositive subjects: evidence for diffuse metabolic abnormalities. Metab Brain Dis (1998) 0.94
A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression. Health Technol Assess (2013) 0.91
Successful treatment of CAPD peritonitis caused by Neisseria cinerea. Perit Dial Int (1994) 0.90
Arsenite activation of P13K/AKT cell survival pathway is mediated by p38 in cultured human keratinocytes. Mol Med (2001) 0.89
Studies of the c-Harvey-Ras gene in psychiatric disorders. Psychiatry Res (1996) 0.89
The metabolic toxicities of antiretroviral therapy. Int J STD AIDS (2001) 0.88
Long-term survival in patients with advanced immunodeficiency. AIDS (1997) 0.87
Cytokine-induced p38 activation feedback regulates the prolonged activation of AKT cell survival pathway initiated by reactive oxygen species in response to UV irradiation in human keratinocytes. Int J Oncol (2001) 0.87
Activity of medial mesopontine units during cataplexy and sleep-waking states in the narcoleptic dog. J Neurosci (1992) 0.87
Management evolution of pulmonary atresia and intact ventricular septum. Am J Cardiol (1993) 0.86
CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects. Clin Exp Immunol (2003) 0.85
Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection. Clin Sci (Lond) (1999) 0.85
Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection. J Antimicrob Chemother (1997) 0.84
Factors associated with racial differences in survival for prostatic carcinoma. J Chronic Dis (1982) 0.84
The relationship of psychological variables and disease progression among long-term HIV-infected men. Int J STD AIDS (2000) 0.84
Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model. Health Technol Assess (2013) 0.83
Antiretroviral therapies in HIV-1 infection. Expert Opin Investig Drugs (1997) 0.83
Recurrent bacterial peritonitis caused by Neisseria cinerea in a chronic ambulatory peritoneal dialysis (CAPD) patient. Diagn Microbiol Infect Dis (1996) 0.81
Bronchopulmonary Kaposi's sarcoma in 106 HIV-1 infected patients. Int J STD AIDS (1998) 0.81
Role of xanthine oxidase in reperfusion injury of ischemic skeletal muscles in the pig and human. J Appl Physiol (1985) (1993) 0.81
Cryptococcal meningitis in pediatric systemic lupus erythematosus. Mycoses (2003) 0.80
Mechanisms of bradykinin-mediated Ca(2+) signalling in canine cultured corneal epithelial cells. Cell Signal (2001) 0.80
Sexual risk behaviours and sexual health outcomes among heterosexual black Caribbeans: comparing sexually transmitted infection clinic attendees and national probability survey respondents. Int J STD AIDS (2011) 0.79
Incidence and risk factors for the development of indinavir-associated renal complications. J Antimicrob Chemother (2001) 0.79
HLA-Cw*0602 and HIV-associated psoriasis. Br J Dermatol (1998) 0.79
Exon and intron variants in the human tryptophan 2,3-dioxygenase gene: potential association with Tourette syndrome, substance abuse and other disorders. Pharmacogenetics (1996) 0.79
Pharmacologic intervention of skin vasospasm and ischemic necrosis in pigs. J Cardiovasc Pharmacol (1993) 0.78
A comparison of two stab-on unipolar epicardial pacing leads in children. Pacing Clin Electrophysiol (1997) 0.78
An association of disseminated Mycoplasma fermentans in HIV-1 positive patients with non-Hodgkin's lymphoma. Int J STD AIDS (2001) 0.78
Surgical repair of coarctation of the aorta in neonates: factors affecting early mortality and re-coarctation. Cardiovasc Surg (1995) 0.78
Adenosine-induced atrial pro-arrhythmia in children. Can J Cardiol (1999) 0.77
Mycoplasma species in rapid and slow HIV progressors. Int J STD AIDS (2000) 0.77
Establishment and characterization of a human monocytoid leukemia cell line, CTV-1. Gan (1984) 0.76
Association between a defective CCR-5 gene and progression to disease in HIV infection. AIDS Res Hum Retroviruses (1998) 0.76
Evolution of heart rate control after transplantation: conduction versus autonomic innervation. Pediatr Cardiol (2003) 0.76
Epidemiological features of drug resistant tuberculosis in Harare, 1994 to 1996. Cent Afr J Med (1999) 0.75
Interrupting antiretroviral treatment needs particular care. BMJ (2001) 0.75
Cross-staining of cytotoxic T lymphocyte populations with peptide-MHC class I multimers of natural HIV-1 variant antigens. AIDS (2001) 0.75
In vitro activity of meropenem against organisms causing serious infections in a Singapore hospital. Int J Antimicrob Agents (1997) 0.75
Interlaboratory comparison of HPLC-fluorescence detection and GC/MS: analysis of PAH compounds present in diesel exhaust. J Hazard Mater (2000) 0.75
Unusual electrophysiological findings in atrioventricular node reentrant tachycardia. Pacing Clin Electrophysiol (1995) 0.75
Intraoperative TEE assessment of ventricular septal defect with aortic regurgitation. Ann Thorac Surg (1996) 0.75
A KpnI DNA polymorphism in the human von Willebrand factor (VWF) gene. Nucleic Acids Res (1990) 0.75
Fetal globin expression in New World monkeys. J Biol Chem (1996) 0.75
Dose properties of a laser accelerated electron beam and prospects for clinical application. Med Phys (2004) 0.75
In vitro activity of cefoperazone-sulbactam: Singapore experience. Southeast Asian J Trop Med Public Health (1996) 0.75
Production of three monoclonal antibodies--A01, B05, and C11--against B-cell leukemia. Haematol Blood Transfus (1987) 0.75
Acid-alcohol fast bacilli in sputa of HIV-infected patients. Int J STD AIDS (1999) 0.75
What is the potential for a heterosexual HIV epidemic in the UK? Int J STD AIDS (1993) 0.75
Vascular effects and mechanism of action of endothelin-1 in isolated perfused pig skin. J Appl Physiol (1985) (1995) 0.75